![glp-1 효능 메디칼타임즈] 대세인 비만약…국내사 차별화 공략 가능할까 학술특집] 최근 당뇨치료의 세계적 이슈,](https://pdscdn.medicaltimes.com/Thumnail/20231106/1699238980.jpg)
Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Neither BPC 157 nor TB 500 is approved by the FDA for human use or for diagnosing, treating, curing, or preventing any disease
![glp-1 ] ] ,](https://cdn.kmedinfo.co.kr/news/photo/201310/11203_2.jpg)
Early clinical trial results are indicating that triple-pathway drugs may deliver greater weight reduction outcomes compared with single-receptor therapies
![glp-1 ] ] ,](http://www.doctorsnews.co.kr/news/photo/202405/154556_122136_2121.jpg)
The goal is to help you look healthier, not simply thinner
![glp-1 ] ] ,](https://m.kbam.co.kr/upload/board/wegovy%20and%20obesity%20drug%20market%20story%202.JPG)
However, in August 2017, GSK announced that it intended to withdraw the drug from the worldwide market by July 2018 for economic reasons
![glp-1 ] ] ,](https://image.news1.kr/system/photos/2025/10/28/7567532/high.jpg/dims/optimize)
- Format: Loaded Pen
![glp-1 ] ] ,](https://lookaside.fbsbx.com/lookaside/crawler/threads/DQMDz-QgYrU/0/image.jpg)
US$ 26.74
US$ 27.25
US$ 20.79
US$ 23.52
US$ 28.88
